Olimel 5.7% 0.15 g

OlimeL 5.7% 0.15G is an intravenous emulsion containing L-Tyrosine, an amino acid essential for protein synthesis. It is used to support nutritional needs in patients requiring parenteral nutrition. This product is manufactured by Baxter Corporation in Canada.

L-Tyrosine is an amino acid that plays a crucial role in the synthesis of proteins and certain neurotransmitters. OlimeL 5.7% 0.15G is typically used in clinical settings to provide essential amino acids to patients who cannot obtain adequate nutrition through oral or enteral routes. It is often part of a comprehensive nutritional support plan for patients undergoing intravenous therapy. The primary use of OlimeL 5.7% 0.15G is to ensure that patients receive the necessary amino acids for maintaining bodily functions and supporting recovery.

When administered intravenously, OlimeL 5.7% 0.15G provides the body with L-Tyrosine, which is utilized for various physiological processes. Patients may experience improved nutritional status and support for metabolic functions. As with any medical intervention, individual responses can vary, and it is important to monitor for any adverse effects.

OlimeL 5.7% 0.15G should be administered under the supervision of a healthcare professional. It is essential to follow proper handling and storage guidelines to maintain the integrity of the emulsion. Patients with known allergies to any of the components should avoid using this product. Always consult a healthcare provider before starting any new treatment.

L-Tyrosine can interact with certain medications and supplements. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Specific interactions may vary, and professional medical advice should be sought to ensure safe and effective use.